FDA sends 2nd noncompliance notice for company failing to post trial results as crackdown ramps up

The FDA is slowly but surely continuing its crackdown on drugmakers that fail to post their clinical trial results to a government database in a timely manner, this week going after Georgia-based Accuitis, which develops new treatments for skin disorders.